Related Experiment Videos
Decrease in the specific forms of cytochrome P-450 in liver microsomes of a mutant strain of rat with
Research Communications in Chemical Pathology and Pharmacology
|May 1, 1991
Summary
Eisai-hyperbilirubinuria rats (EHBR) show altered drug metabolism enzyme activity. Specifically, cytochrome P-450 levels are form-specifically changed in EHBR liver microsomes compared to controls.
Area of Science:
- Pharmacology
- Biochemistry
- Toxicology
Background:
- Eisai-hyperbilirubinuria rats (EHBR) are a mutant strain derived from Sprague Dawley rats.
- Understanding drug metabolism differences in EHBR is crucial for toxicological studies.
Purpose of the Study:
- To compare drug-metabolizing enzyme activities in EHBR with Sprague Dawley rats.
- To investigate alterations in cytochrome P-450 enzyme expression in EHBR.
Main Methods:
- Enzyme activity assays for UDP-glucuronyltransferase and specific drug metabolizing enzymes.
- Western blot analysis using antibodies against various cytochrome P-450 isoforms (P-450IA2, P-450IIB1, P-450IIC11, P-450IIIA2).
Main Results:
- Increased aniline hydroxylase and testosterone 7 alpha-hydroxylase activity in EHBR.
- Decreased ethylmorphine N-demethylase and testosterone 6 beta-hydroxylase activity in EHBR.
- Significantly lower protein levels of P-450IIB1 and P-450IIIA2 in EHBR liver microsomes.
Conclusions:
- EHBR exhibits form-specific alterations in cytochrome P-450 expression.
- These findings highlight significant differences in drug metabolism pathways between EHBR and control rats.